Baudax Bio Inc expected to post a loss of $2.04 a share - Earnings Preview

Baudax Bio

07/08/2023 14:21

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
fall in
quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for a
loss of $2.04 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$24​, above​ its last closing price of $0.63. ​​​

This summary was machine generated August 7 at 13:21 GMT.  All
figures in US dollars  unless otherwise stated